MonteMir-LC is a combination formulation containing Montelukast Sodium 4 mg + Levocetirizine 2.5 mg, intended for the management of allergy-related respiratory symptoms.

Formulation: Montelukast Sodium 4 mg + Levocetirizine 2.5 mg
Packaging: 60 ml Syrup

Product Description:
MonteMir-LC combines Montelukast, a leukotriene receptor antagonist, with Levocetirizine, an antihistamine. The formulation helps relieve symptoms associated with allergic rhinitis, including sneezing, runny or itchy nose, and nasal congestion. It may also be used as part of therapy for allergy-associated respiratory symptoms, as directed by a qualified healthcare professional.